Samsung Biologics
Samsung Biologics is a South Korean biotechnology company recognized for its rapid growth and investment in large-scale biomanufacturing facilities. Established to provide contract manufacturing services for biopharmaceuticals, the company has emerged as a global leader in the industry, focusing on strategic expansions and partnerships to enhance its market position.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 7.00 | 0.08% | +0% | 8,654,622 | 6,622 | $700,000 | 536$ |
| Totals | 1 | 8,654,622 | 6,622 | $700,000 | 536$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Samsung Biologics is pursuing an acquisition of Polypeptide to strengthen its position in the peptide manufacturing market.
7